WEKO3
インデックスリンク
アイテム
{"_buckets": {"deposit": "0ddf68df-cb21-4999-b69f-b78d6b30391c"}, "_deposit": {"created_by": 3, "id": "14732", "owners": [3], "pid": {"revision_id": 0, "type": "depid", "value": "14732"}, "status": "published"}, "_oai": {"id": "oai:kanazawa-u.repo.nii.ac.jp:00014732", "sets": ["1134"]}, "author_link": ["297", "284", "26271"], "item_4_biblio_info_8": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2000-02-20", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "1", "bibliographicPageEnd": "37", "bibliographicPageStart": "33", "bibliographicVolumeNumber": "40", "bibliographic_titles": [{"bibliographic_title": "肺癌"}, {"bibliographic_title": "Japanese journal of lung cancer", "bibliographic_titleLang": "en"}]}]}, "item_4_description_21": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Objective : To ascertain the clinical impression that hiccups are frequently observed during cisplatin (CDDP)-based chemotherapy for lung cancer, and to clarify onset, duration and therapeutic intervention of this troublesome symptom. Methods : Thirteen patients who received systemic chemotherapy for lung cancer from April 1997 to May 1998 were included in this retrospective analysis. The information about occurrence of hiccup was obtained from medical and nursing records. Results : Nine patients received CDDP-based chemotherapy. They simultaneously received prophylactic antiemetic therapy with a 5-HT3 receptor antagonist and dexamethasone. Hiccups were observed in 8 of 9 patients and in 11 courses among a total of 24 courses. Hiccups began at 18 to 42 hours (median 26 hours) after starting CDDP infusion, and lasted for 1 to 37 hours (median 11 hours). None of the four patients who received only non-CDDP based therapy experienced hiccups. Conclusion : Hiccups were frequently observed during CDDP-based chemotherapy for lung cancer. 肺癌患者に対し, シスプラチンを中心とする化学療法を施行した際, 5HT_3受容体拮抗剤とステロイド剤の併用による標準的な予防的制吐療法を行った場合, 経験的に高頻度に吃逆が観察される.我々は1997年4月から約1年間に全身化学療法を施行した13例の肺癌患者について, 吃逆の発生状況をretrospectiveに検討した.CDDPベースの化学療法は9例に行われ, 前例で5-HT_3受容体拮抗剤とステロイド剤の併用による制吐療法が行われていた.このうち1例を除く8例, 総投与コース数24コース中11コースで吃逆が認められた.吃逆はCDDP投与開始後18〜42時間後(中央値26時間後)に発生し, 1〜37時間(中央値11時間)持続し, 最長でも58時間後には停止した.CDDPを使用しなかった4例では吃逆を認めなかった.CDDPベースの化学療法に標準的制吐療法を行った場合, 高頻度に吃逆を認めることが明らかとなった.", "subitem_description_type": "Abstract"}]}, "item_4_description_5": {"attribute_name": "提供者所属", "attribute_value_mlt": [{"subitem_description": "金沢大学医薬保健研究域医学系", "subitem_description_type": "Other"}]}, "item_4_identifier_registration": {"attribute_name": "ID登録", "attribute_value_mlt": [{"subitem_identifier_reg_text": "10.24517/00014719", "subitem_identifier_reg_type": "JaLC"}]}, "item_4_publisher_17": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "Japanese Lung Cancer Society = 日本肺癌学会"}]}, "item_4_relation_28": {"attribute_name": "関連URI", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "http://www.haigan.gr.jp/", "subitem_relation_type_select": "URI"}}, {"subitem_relation_type_id": {"subitem_relation_type_id_text": "http://ci.nii.ac.jp/naid/110003111426/en/", "subitem_relation_type_select": "URI"}}]}, "item_4_rights_23": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "Copyright (c) 2000 日本肺癌学会 : 本文データは学協会の許諾に基づきCiNiiから複製したものである relation: isVersionOf: http://ci.nii.ac.jp/naid/110003111426/en/"}]}, "item_4_source_id_11": {"attribute_name": "NCID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00203978", "subitem_source_identifier_type": "NCID"}]}, "item_4_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0386-9628", "subitem_source_identifier_type": "ISSN"}]}, "item_4_version_type_25": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "柴田, 和彦"}], "nameIdentifiers": [{"nameIdentifier": "26271", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "笠原, 寿郎"}], "nameIdentifiers": [{"nameIdentifier": "284", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "30272967", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=30272967"}, {"nameIdentifier": "30272967", "nameIdentifierScheme": "金沢大学研究者情報", "nameIdentifierURI": "http://ridb.kanazawa-u.ac.jp/public/detail.php?kaken=30272967"}, {"nameIdentifier": "30272967", "nameIdentifierScheme": "研究者番号", "nameIdentifierURI": "https://nrid.nii.ac.jp/nrid/1000030272967"}]}, {"creatorNames": [{"creatorName": "藤村, 政樹"}], "nameIdentifiers": [{"nameIdentifier": "297", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "90190066", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=90190066"}, {"nameIdentifier": "90190066", "nameIdentifierScheme": "研究者番号", "nameIdentifierURI": "https://nrid.nii.ac.jp/nrid/1000090190066"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2017-10-03"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "ME-PR-FUJIMURA-M-33.pdf", "filesize": [{"value": "448.0 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 448000.0, "url": {"label": "ME-PR-FUJIMURA-M-33.pdf", "url": "https://kanazawa-u.repo.nii.ac.jp/record/14732/files/ME-PR-FUJIMURA-M-33.pdf"}, "version_id": "bb0c312e-667c-48c2-8956-e4ef99ffc702"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "5-HT3 receptor antagonist", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Antiemetic therapy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Cisplatin", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Dexamethasone", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Hiccup", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "肺癌化学療法における吃逆に関する検討", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "肺癌化学療法における吃逆に関する検討"}, {"subitem_title": "Hiccup Observed during Chemotherapy for Lung Cancer", "subitem_title_language": "en"}]}, "item_type_id": "4", "owner": "3", "path": ["1134"], "permalink_uri": "https://doi.org/10.24517/00014719", "pubdate": {"attribute_name": "公開日", "attribute_value": "2017-10-03"}, "publish_date": "2017-10-03", "publish_status": "0", "recid": "14732", "relation": {}, "relation_version_is_last": true, "title": ["肺癌化学療法における吃逆に関する検討"], "weko_shared_id": 3}
肺癌化学療法における吃逆に関する検討
https://doi.org/10.24517/00014719
https://doi.org/10.24517/00014719409dd1ab-c920-4e6a-9ba5-4a01d892e637
名前 / ファイル | ライセンス | アクション |
---|---|---|
ME-PR-FUJIMURA-M-33.pdf (448.0 kB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2017-10-03 | |||||
タイトル | ||||||
タイトル | 肺癌化学療法における吃逆に関する検討 | |||||
タイトル | ||||||
言語 | en | |||||
タイトル | Hiccup Observed during Chemotherapy for Lung Cancer | |||||
言語 | ||||||
言語 | jpn | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
ID登録 | ||||||
ID登録 | 10.24517/00014719 | |||||
ID登録タイプ | JaLC | |||||
著者 |
柴田, 和彦
× 柴田, 和彦× 笠原, 寿郎× 藤村, 政樹 |
|||||
提供者所属 | ||||||
内容記述タイプ | Other | |||||
内容記述 | 金沢大学医薬保健研究域医学系 | |||||
書誌情報 |
肺癌 en : Japanese journal of lung cancer 巻 40, 号 1, p. 33-37, 発行日 2000-02-20 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0386-9628 | |||||
NCID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AN00203978 | |||||
出版者 | ||||||
出版者 | Japanese Lung Cancer Society = 日本肺癌学会 | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Objective : To ascertain the clinical impression that hiccups are frequently observed during cisplatin (CDDP)-based chemotherapy for lung cancer, and to clarify onset, duration and therapeutic intervention of this troublesome symptom. Methods : Thirteen patients who received systemic chemotherapy for lung cancer from April 1997 to May 1998 were included in this retrospective analysis. The information about occurrence of hiccup was obtained from medical and nursing records. Results : Nine patients received CDDP-based chemotherapy. They simultaneously received prophylactic antiemetic therapy with a 5-HT3 receptor antagonist and dexamethasone. Hiccups were observed in 8 of 9 patients and in 11 courses among a total of 24 courses. Hiccups began at 18 to 42 hours (median 26 hours) after starting CDDP infusion, and lasted for 1 to 37 hours (median 11 hours). None of the four patients who received only non-CDDP based therapy experienced hiccups. Conclusion : Hiccups were frequently observed during CDDP-based chemotherapy for lung cancer. 肺癌患者に対し, シスプラチンを中心とする化学療法を施行した際, 5HT_3受容体拮抗剤とステロイド剤の併用による標準的な予防的制吐療法を行った場合, 経験的に高頻度に吃逆が観察される.我々は1997年4月から約1年間に全身化学療法を施行した13例の肺癌患者について, 吃逆の発生状況をretrospectiveに検討した.CDDPベースの化学療法は9例に行われ, 前例で5-HT_3受容体拮抗剤とステロイド剤の併用による制吐療法が行われていた.このうち1例を除く8例, 総投与コース数24コース中11コースで吃逆が認められた.吃逆はCDDP投与開始後18〜42時間後(中央値26時間後)に発生し, 1〜37時間(中央値11時間)持続し, 最長でも58時間後には停止した.CDDPを使用しなかった4例では吃逆を認めなかった.CDDPベースの化学療法に標準的制吐療法を行った場合, 高頻度に吃逆を認めることが明らかとなった. | |||||
権利 | ||||||
権利情報 | Copyright (c) 2000 日本肺癌学会 : 本文データは学協会の許諾に基づきCiNiiから複製したものである relation: isVersionOf: http://ci.nii.ac.jp/naid/110003111426/en/ | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
関連URI | ||||||
識別子タイプ | URI | |||||
関連識別子 | http://www.haigan.gr.jp/ | |||||
関連URI | ||||||
識別子タイプ | URI | |||||
関連識別子 | http://ci.nii.ac.jp/naid/110003111426/en/ |